Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2021-10-06 | Desney Tan is a newly-nominated candidate for director. If elected, we expect to appoint him to our compensation committee. ... Dr. Tan is vice president for research and incubation within Microsoft’s Health and Life Science program, a role he has held since September 1, 2021. ... Dr. Tan was first recommended to us by a search firm retained by the nominating and governance committee. Dr. Tan’s experience in digital health technologies and artificial intelligence, and his current executive position led our board to conclude he should serve as a director. |
| 2022-10-05 | Desney Tan has served as a ResMed director since November 2021. He is a member of the compensation committee. ... Fiscal year 2022 director compensation table ... Desney Tan $43,750 fees earned in cash, $249,975 option awards, total $293,725. |
| 2023-10-05 | Desney Tan has served as a ResMed director since November 2021. He is a member of the compensation committee. ... Dr. Tan’s experience in digital health technologies and artificial intelligence, and his current executive position led our board to conclude he should serve as a director. |
| 2024-10-03 | Desney Tan | 48 Independent Corporate Vice President and Managing Director of Microsoft Research Director since: 2021 Committees: Compensation |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22